Trademark Search in Canada

PROTAGONIST THERAPEUTICS

View On IC.GC.CA

FORMALIZED

on 6 Mar 2024

Last Applicant/ Owned by

Protagonist Therapeutics, Inc.

7707 Gateway Blvd. Suite 210Newark CA 94560

Serial Number

2314158 filed on 3^rd Jan 2024

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

PROTAGONIST THERAPEUTICS

Trademark usage description

pharmaceutical preparations for the treatment of oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocri Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders.

Classification kind code

Class [042]
Scientific and medical research relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders.

Classification kind code

Class [044]
Providing online information to patients and healthcare providers relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders.

Classification kind code

Mark Details

Serial Number

2314158

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 256 on 7^th Jan 2025	Notification of Possible Opposition Sent
Submitted for opposition 48 on 21^st Mar 2024	Agent Changed
Submitted for opposition 257 on 7^th Mar 2024	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 6^th Mar 2024	Created
Submitted for opposition 31 on 6^th Mar 2024	Formalized
Submitted for opposition 228 on 3^rd Jan 2024	International Registration
Submitted for opposition 30 on 3^rd Jan 2024	Filed

PROTAGONIST THERAPEUTICS

Classification Information

Class [005]Pharmaceutical preparations for the treatment of oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders.

Classification kind code

Class [042]Scientific and medical research relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders.

Classification kind code

Class [044]Providing online information to patients and healthcare providers relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparations for the treatment of oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders.

Class [042]
Scientific and medical research relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders.

Class [044]
Providing online information to patients and healthcare providers relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders.